28
Actinomycetota- The Future in Infectious Diseases
I am a Microbiologist specializing in the study of primary and secondary
metabolites produced by Actinomycetota( formerly Actinobacteria), a prolific group of soil-dwelling bacteria renowned for their ability to synthesize clinically important antibiotics and diverse bioactive compounds.
Dr Adzzie Shazleen binti Azman adzzieshazleen. azman @ monash. edu
Lecturer
Expertise
Expertise Bacteriology Public Actinomycetota health Education Antimicrobial study Financial statistics
Achievement / Award SG Academies South-East Asia Fellowship 2023- Singapore National Academy of Science( 2023)
My research focuses on the isolation and characterization of potentially novel strains and the in-depth investigation of their metabolite profiles. By exploring the antimicrobial properties and underlying the mechanisms of these metabolites, I aim to identify new therapeutic candidates, particularly for the treatment of challenging infections such as biofilmassociated wound infections and acnerelated pathogens.
This work supports the global effort to discover innovative solutions to antibiotic resistance and the treatment of persistent, drug-tolerant bacterial infections, classified as a major health concern by the World Health
Organisation.
Streptomyces sp. KSF 165
Let’ s explore the world of Actinomycetota and discover their potential use in treating the infectious diseases for a better health and world
SCHOOL OF SCIENCE CAPABILITIES